Total Valuation
Eurobio-Scientific SA has a market cap or net worth of €200.11M. The enterprise value is €240.50.
Market Cap€200.11M
Enterprise Value€240.50
Share Statistics
Eurobio-Scientific SA has 10,248,871 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,248,871
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Eurobio-Scientific SA’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 4.48%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)4.48%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee492.71K
Profits Per Employee14.18K
Employee Count343
Asset Turnover0.66
Inventory Turnover3.51
Valuation Ratios
The current PE Ratio of Eurobio-Scientific SA is 42.6. Eurobio-Scientific SA’s PEG ratio is 2.53.
PE Ratio42.6
PS Ratio1.48
PB Ratio1.36
Price to Fair Value1.36
Price to FCF39.72
Price to Operating Cash Flow12.16
PEG Ratio2.53
Income Statement
In the last 12 months, Eurobio-Scientific SA had revenue of 169.00M and earned 4.87M in profits. Earnings per share was 0.47.
Revenue169.00M
Gross Profit68.40M
Operating Income15.45M
Pretax Income7.80M
Net Income4.87M
EBITDA32.04M
Earnings Per Share (EPS)0.47
Cash Flow
In the last 12 months, operating cash flow was 17.14M and capital expenditures -12.57M, giving a free cash flow of 4.57M billion.
Operating Cash Flow17.14M
Free Cash Flow4.57M
Free Cash Flow per Share0.45
Dividends & Yields
Eurobio-Scientific SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.21
52-Week Price Change-14.46%
50-Day Moving Average21.53
200-Day Moving Average22.95
Relative Strength Index (RSI)45.12
Average Volume (3m)0.00
Important Dates
Eurobio-Scientific SA upcoming earnings date is Oct 13, 2026, Before Open (Confirmed).
Last Earnings DateApr 10, 2026
Next Earnings DateOct 13, 2026
Ex-Dividend Date―
Financial Position
Eurobio-Scientific SA as a current ratio of 1.98, with Debt / Equity ratio of 8.71%
Current Ratio1.98
Quick Ratio1.36
Debt to Market Cap0.04
Net Debt to EBITDA-0.13
Interest Coverage Ratio7.73
Taxes
In the past 12 months, Eurobio-Scientific SA has paid 2.94M in taxes.
Income Tax2.94M
Effective Tax Rate0.38
Enterprise Valuation
Eurobio-Scientific SA EV to EBITDA ratio is 7.65, with an EV/FCF ratio of 39.04.
EV to Sales1.45
EV to EBITDA7.65
EV to Free Cash Flow39.04
EV to Operating Cash Flow13.01
Balance Sheet
Eurobio-Scientific SA has €20.66M in cash and marketable securities with €16.02M in debt, giving a net cash position of €4.65M billion.
Cash & Marketable Securities€20.66M
Total Debt€16.02M
Net Cash€4.65M
Net Cash Per Share€0.45
Tangible Book Value Per Share€3.16
Margins
Gross margin is 44.71%, with operating margin of 9.14%, and net profit margin of 2.88%.
Gross Margin44.71%
Operating Margin9.14%
Pretax Margin4.62%
Net Profit Margin2.88%
EBITDA Margin18.96%
EBIT Margin9.14%
Analyst Forecast
The average price target for Eurobio-Scientific SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.08%
EPS Growth Forecast21.19%